Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02807272
Title Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia (CMML)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kura Oncology, Inc.
Indications

myelodysplastic/myeloproliferative neoplasm

Therapies

Tipifarnib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.